Mortality. · adult parapneumonic effusions and empyema
Fibrinolytics showed no clear difference in mortality. compared with placebo (moderate certainty).
1 finding from 1 review
Referral for thoracic surgery (open or thorascopic) · adult parapneumonic effusions and empyema
Fibrinolytics may leads to lower referral for thoracic surgery. compared with placebo (low certainty).
1 finding from 1 review
Overall treatment failure, including mortality, thoracic surgery or referral for further fibrinolytic therapy · adult parapneumonic effusions and empyema
It is very uncertain whether fibrinolytics changes overall treatment failure, including mortality, thoracic surgery or… compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · adult parapneumonic effusions and empyema
Fibrinolytics showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Menstrual blood loss: mean loss · women with heavy menstrual bleeding
1 finding from 1 review
Menstrual blood loss: improvement rates · women with heavy menstrual bleeding
Antifibrinolytics may leads to higher menstrual blood loss: improvement rates compared with NSAIDs (low certainty).
1 finding from 1 review
Adverse events (any) · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thromboembolic events · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss: mean loss · women with heavy menstrual bleeding
1 finding from 1 review
Menstrual blood loss: improvement rates · women with heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes menstrual blood loss: improvement rates compared with ethamsylate (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · women with heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes withdrawal from treatment because of adverse events compared with ethamsylate (very low certainty).
1 finding from 1 review
Thromboembolic events · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss: mean loss · heavy menstrual bleeding
2 findings from 1 review
Rates of improvement · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss: improvement rates · women with heavy menstrual bleeding
Antifibrinolytics probably leads to higher menstrual blood loss: improvement rates compared with no treatment or placebo (moderate certainty).
1 finding from 1 review
Adverse events (any) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes adverse events (any) compared with herbal medicines (very low certainty).
1 finding from 1 review
Thromboembolic events · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss PBAC score · heavy menstrual bleeding
1 finding from 1 review
Menstrual blood loss: improvement in mean blood loss (PBAC score < 100) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes menstrual blood loss: improvement in mean blood loss (PBAC score <… compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Adverse events (any) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes adverse events (any) compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review